In response to EGCG treatment, the observed reduction in ERK1/2 phosphorylation in colon, pancreatic and lung cancer cells was found to promote the expression of the Bcl‐2 family of apoptotic proteins [107]. This evidence concerns the gene BCL2 and lung carcinoma.